Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling-Reference-Cited by-同舟云学术

Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling

Published:2019-11 Issue: Volume:139 Page:105061
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Zhou Li^ORCID,Sharma Pradeep,Yeo Karen Rowland,Higashimori Mitsuo,Xu Hongmei,Al-Huniti Nidal,Zhou Diansong

Funder

AstraZeneca Pharmaceuticals LP

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference75 articles.

1. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation;Akil;J. Pharmacokinet. Pharmacodyn.,2016

2. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update;Alex;Curr. Drug Metab.,2002

3. Pharmacometric modeling of naloxegol efficacy and safety: impact on dose and label;Al-Huniti;Clin. Pharmacol. Ther.,2017

4. Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects;Andersson;Pharmacogenetics,1992

5. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole;Andersson;Br. J. Clin. Pharmacol.,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A physiologically based pharmacokinetic model of voriconazole in human CNS—Integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and possible transporter mechanisms;International Journal of Antimicrobial Agents;2024-10

2. PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox;Drug development & registration;2024-08-27

3. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis;Translational Psychiatry;2024-07-19

4. The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine;The Application of Clinical Genetics;2024-07

5. Physiologically based pharmacokinetic modeling to predict the clinical effect of azole antifungal agents as CYP3A inhibitors on azelnidipine pharmacokinetics;Drug Metabolism and Pharmacokinetics;2024-04